Jim Simons’s Revolution Medicines RVMD Stock Holding History

Jim Simons’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$603K	Buy	+6,200	New	+$626K	﹤0.01%	2522
2025 Q4	–	Sell	-253,104	Closed	-$11.8M	–	3681
2025 Q3	$11.8M	Buy	253,104 +9,600	+4%	+$376K	0.02%	1008
2025 Q2	$8.96M	Buy	243,504 +100,700	+71%	+$3.87M	0.01%	1127
2025 Q1	$5.05M	Buy	+142,804	New	+$5.8M	0.01%	1426
2023 Q2	–	Sell	-43,300	Closed	-$938K	–	4218
2023 Q1	$938K	Buy	+43,300	New	+$1.07M	﹤0.01%	2521
2022 Q4	–	Sell	-68,900	Closed	-$1.36M	–	4357
2022 Q3	$1.36M	Buy	+68,900	New	+$1.51M	﹤0.01%	2297
2022 Q1	–	Sell	-55,100	Closed	-$1.39M	–	4403
2021 Q4	$1.39M	Buy	+55,100	New	+$1.55M	﹤0.01%	2425
2021 Q3	–	Sell	-22,900	Closed	-$727K	–	3787
2021 Q2	$727K	Buy	22,900 +13,300	+139%	+$464K	﹤0.01%	2806
2021 Q1	$440K	Buy	+9,600	New	+$430K	﹤0.01%	2954

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jim Simons's RVMD Position: Q1 2026 in Review

Jim Simons opened a new position in Revolution Medicines (RVMD) in Q1 2026: 6,200 shares worth $603K. The stake represents ﹤0.01% of the portfolio and ranks #2522 among its holdings. This is a return to the name: Jim Simons previously reported a position in RVMD as recently as Q3 2025.

Jim Simons first reported a position in RVMD in Q1 2021 and has held it in 9 quarters since. The position peaked at $11.8M in Q3 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Jim Simons held 6,200 shares of Revolution Medicines worth $603K as of Q1 2026.
Revolution Medicines was a new Jim Simons position in Q1 2026.
Revolution Medicines made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2522 holding.
Jim Simons first reported a position in Revolution Medicines in Q1 2021 and has held it in 9 quarters since.
Jim Simons's Revolution Medicines position peaked at $11.8M in Q3 2025.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.